「japan」の検索結果
89件：71～75件目を表示
-
y 9, 2024 Senju Pharmaceutical Co., Ltd. Senju announces initiation of Phase III Clinical Trials in Japan for “SJP-0008” for the treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co.,...
https://www.senju.co.jp/system/files/content_news/2024-05/ENG_20240509_0.pdf -
y 9, 2024 Senju Pharmaceutical Co., Ltd. Senju announces initiation of Phase III Clinical Trials in Japan for “SJP-0008” for the treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co.,...
https://www.senju.co.jp/system/files/content_news/2024-05/ENG_20240509.pdf -
研发产品管线 | 研究与开发 | 千寿制药株式会社
PROGRESS OF DEVELOPMENT 临床试验一期以后的公开信息 药品适应症状态（地区） SJP-0132Dry eyeApproval（Japan） PranoprofeninflammationApplication under review (Vietnam) SJP-0132Dry eyeP3（China） SJP-0008Central Retinal Artery Occlu...
http://www.senju.co.jp/chinese/rd/pipeline.html -
R&D Pipeline | Research & Development | SENJU Pharmaceutica
ENT Disclosuring of information after Phase 1 DrugIndicationStatus (Region) SJP-0132Dry eyeApproval（Japan） PranoprofeninflammationApplication under review (Vietnam) SJP-0132Dry eyeP3（China） SJP-0008Ce...
http://www.senju.co.jp/english/rd/pipeline.html -
Ltd. Mochida Pharmaceutical Co., Ltd. Senju has Applied for Manufacturing and Marketing Approval in Japan for the novel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117_0.pdf